Neoadjuvant Bevacizumab with Weekly Nab-Paclitaxel Plus Carboplatin Followed by Doxorubicin Plus Cyclophosphamide (ac) for Triple-Negative Breast Cancer
JOURNAL OF CLINICAL ONCOLOGY（2012）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined